Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Expert Panel Issues Final Consensus Statement on Skin Changes at Life’s End (SCALE)
Panel determines that current understanding of this complex phenomenon is limited and that additional research is necessary - December 02, 2009 - Gaymar Industries
KLIXAR Joins Health Decisions’ Global Network of CROs Advocating Higher Efficiency Standards
Latin American CRO is now a certified partner in Health Decisions’ Agile Clinical Network, dedicated to improving processes and systems across global trials - November 20, 2009 - Health Decisions
Hamner Institutes Scientist to Speak at Conference Focusing on Military Life Sciences Initiatives
The Hamner Institutes for Health Sciences has announced that Melvin Andersen, Ph.D., director of The Hamner Program in Chemical Safety Sciences and director of the Computational Biology Division, will join a panel at the U.S. Department of Defense’s Transformational Medical Technologies... - November 19, 2009 - The Hamner Institutes for Health Sciences
News at MEDICA: ALPCO Announces the Launch of Several New Products in 2009
ALPCO will return to MEDICA, showcasing these new immunoassay kits, which cement the company's perennial committment to serving the demands of the pre-clinical research market. This will be ALPCO's fourth year at MEDICA as part of the “Best of New England” consortium of companies, located in the US pavilion in Halle 3, D15-4. - November 16, 2009 - ALPCO
CuraBase to be Presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therpeutics Conference in Boston
Targeted Therapeutics Consulting, Inc. announced today that its lead product, the cancer drug development database CuraBase®, will be introduced to the scientific community at the AACR-NCI-EORTC Molecular Targets and Cancer Therpeutics Conference in Boston on Monday, November 16. Dr. W. Michael... - November 14, 2009 - Targeted Therapeutics Consulting, Inc.
Symbyos Announces Its ToothIQ Dental Videos Are Now Available for Dentist Websites
Symbyos, the developers of ToothIQ have released their dental animations to dentists for use on their own practice websites via ToothIQPro. - November 11, 2009 - Symbyos
Dr. Ann A. Kiessling, Director of the Bedford Stem Cell Research Foundation Honored with the Jacob Heskel Gabbay Award for Biotechnology and Medicine
101 healthy babies have been born from SPAR, the Special Program of Assisted Reproduction, which allows HIV positive men to safely father children. Dr. Kiessling’s recent work is bridging the gap between assisted reproduction and stem cell science. - November 09, 2009 - Bedford Stem Cell Research Foundation
ENCO Pharmaceutical Development Announces Selection of LabWare as Its LIMS Provider
ENCO Pharmaceutical Development, Inc. acquires a state-of-the-art LabWare laboratory information management system for its faciities. - October 30, 2009 - Enco Pharmaceutical Development, Inc.
XTractor Premium Scales a New Milestone as It Surpasses 300,000 Mark of Expert Annotated PubMed Facts
Premium platform surpasses 302,269 "Expert" annotated facts from PubMed. XTractor is also available as LinkOut service of Entrez gene that allows to link XTractor directly from Entrez databases to a wide range of information and services beyond the Entrez system. - October 25, 2009 - Molecular Connections Pvt. Ltd.
Moms on a Mission: Will Moms of America be the Champions of Change?
Two moms, from opposite ends of the country, who have yet to meet, answer the call to action with an astounding "yes." - October 19, 2009 - Brad Kaminsky Foundation for Brain Tumor Research
Health Decisions Builds a Network of International CROs Trained in High-Efficiency Adaptive Research
Adaptive CRO invites like-minded research organizations from around the world to get certified in Agile Clinical Development - October 18, 2009 - Health Decisions
LCH Clinical Research, LLC to Host Wine and Cheese Networking Event
LCH Clinical Research, LLC, an Atlanta-based research company announces its networking event Lynn Harding, CEO of LCH Clinical Research has over 15 years of experience in clinical research. She is a key leader in a movement to make LCH Clinical Research the premiere destination for clinical... - October 16, 2009 - LCH Clinical Research, LLC
ALPCO Introduces Immundiagnostik Bone Sialoprotein (BSP) ELISA to North America
ALPCO Diagnostics introduces Immundiagnostik's Bone Sialoprotein ELISA to North America. The BSP ELISA exhibits outstanding sensitivity and specificity for the underglycosylated or carbohydrate deficient Bone Sialoprotein. - October 15, 2009 - ALPCO
The Hamner Institutes For Health Sciences Launches Twitter Page
The Hamner Institutes for Health Sciences has announced the official launch of its Twitter page (www.twitter.com/thehamner). The nonprofit research organization will use the account to report news and happenings, engage the scientific and local communities, and share research on chemical and drug... - October 15, 2009 - The Hamner Institutes for Health Sciences
Study: the New Buzz on Detecting Tinnitus
A Henry Ford Hospital study finds that a non-invasive imaging technique can aid in the diagnosis of tinnitus, a perceived ringing of the head and ears, offering hope to the more than 50 million patients with tinnitus. This imaging technique can determine the site of perception of tinnitus in the brain, which could in turn allow physicians to target the area with electrical or chemical therapies to lessen symptoms. - October 07, 2009 - Henry Ford Health System
ALPCO and Athera Biotechnologies Sign Distribution Agreement in North America
ALPCO Diagnostics, a leading developer and distributor of high quality immunoassay kits, is pleased to announce that they have signed with Athera Biotechnologies as their new distribution channel in the North America. Sean Conley, COO of ALPCO, said “We are very excited about the... - October 06, 2009 - ALPCO
New HD360˚ Module Gives Clinical Trial Monitors Greater Control While Reducing Costs
Health Decisions integrates Monitor View into its HD360˚ clinical trial management system. - September 27, 2009 - Health Decisions
RayBiotech to Award Biomarker Discovery Grants
RayBiotech, Inc., today announced today the establishment of its Biomarker Discovery Pilot Grant program, consisting of restricted grants of $10,000 to $20,000 worth of RayBiotech products and services to conduct their proposed biomarker research, which would potentially be sufficient to generate preliminary data for additional grant funding. - September 26, 2009 - RayBiotech, Inc
MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014
The biosimilars market is highly fragmented and its huge opportunities are attracting new players. Favourable regulatory developments in the biosimilars sector are expected to increase the market share and profit margins while reducing medical expenditure. - September 25, 2009 - marketsandmarkets
MedSource Hires New Associate Director of Clinical Operations
MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced today that Ms. Parisa Jabbarzadegan has joined its company as Associate Director of Clinical Operations. With more than 12 years of experience in the clinical research industry she brings a... - September 25, 2009 - MedSource
Cerno Bioscience’s MassWorksTM Has Proven to be 99% Accurate Software for the Identification of Unknown Compounds
MassWorks employs Cerno’s patented calibration technology to equip unit mass resolution mass spectrometers with up to 100 times more mass accuracy and unparallel Spectral Accuracy through exact isotope modeling. Through MassWorks, customers can utilize unit mass resolution mass spectrometers to identify the formulas of unknown compounds. This function, before MassWorks, was usually reserved for more expensive high resolution mass spectrometers. - September 22, 2009 - Cerno Bioscience
Block Imaging Announces Acquisition and New Subsidiary Company
Block Imaging International, Inc., the premier global provider of Pre-owned and Refurbished Medical Imaging Systems, Parts, and Services, announced today its acquisition of Benchmark Radiology LLC., headquartered near Ft. Wayne, IN. Block Imaging also announced today the establishment of a new... - September 17, 2009 - Block Imaging
Lupus Research Institute National Coalition Goes to Washington
LRI Advocacy Day on the Hill Promotes Health Care Concerns of Lupus Patients. - September 17, 2009 - Lupus Research Institute
DZS Software’s Clinical Trial Management Software (CTMS) Selected by PhotoThera, Inc., a Carlsbad, California Medical Device Manufacturer
ClinPlus® web-based (CTMS) proves to be best choice for proprietary device technology using transcranial laser therapy (TLT) for the treatment of acute ischemic stroke and other neurological diseases and disorders. - September 16, 2009 - DZS Software Solutions
Center for Autism and Related Disorders' Study Finds Chewing Gum an Effective Treatment for Rumination in Children with Autism
CARD research team discovers chewing gum to be a practical and effective treatment to prevent rumination in children with autism. The complete study is published in the Summer 2009 Edition of the Journal of Applied Behavior Analysis. - September 10, 2009 - Center for Autism and Related Disorders
Outsourced Paralegal Services LLC Asserts Link Between Chapter 7 & 13 Bankruptcy Filings and Medical Bills
Consumer bankruptcy freelance paralegal company Outsourced Paralegal Services, LLC examines connection between chronic illness and consumer bankruptcy filings. - September 03, 2009 - Outsourced Paralegal Services
Founding Members of Initiatives Healthcare Bring Unprecedented Leadership to Florence Arizona Hospital, Tri-Valley Region
Edward McEachern, MD, CEO and Brent Cherne, CPA, CFO, combine talents to bring experience and leadership to the new hospital being constructed in Florence Arizona. Florence Community Healthcare will open its doors in late Fall 2009. - September 03, 2009 - Florence Community Healthcare
Lupus Research Institute Encouraged by Phase 2 Trial Results of Experimental Drug Epratuzumab
The Lupus Research Institute (LRI) and its National Coalition of state and local organizations congratulate Immunomedics and UCB on the successful results of the Phase 2b clinical trial of epratuzumab for people with systemic lupus. “It is heartening to see success in lupus trials and to see... - September 03, 2009 - Lupus Research Institute
AAA Measurement Men LLC, Now Provides Reverse Engineering Utilizing Their Faro Laser Scanner Which Creates Point Clouds From Products Into Solid 3D Models
They've acquired the technology & experience to convert scanned product from Point Clouds into a Solid 3D Model. Very few companies have the technology & resources for this service. - August 27, 2009 - AAA Measurement Men LLC
From Tragedy to Triumph: Five Year-Old Victim of Domestic Violence with Severed Facial Nerves is Smiling Again After Cutting-Edge Facial Plastic Surgery in San Salvador
Madeline is a 5-year-old who was atrociously slashed earlier this year by her father in a domestic violence act in her home in San Salvador. As luck would have it, Dr. Babak Azizzadeh, the director of the Facial Paralysis & Bell’s Palsy Foundation was on a medical mission trip in... - August 20, 2009 - Facial Paralysis Institute
Caffeine Cuts Male Mating Success
New study suggests that, when long-term effects are considered, two commonly ingested stimulants are not created equal. - August 19, 2009 - Genescient Corporation
Home Health Plays Critical Role in Patient Medication Adherence
New England Healthcare Institute study reports health care teams could help save billions in avoidable costs related to patients who do not properly take their medications. - August 16, 2009 - Home Care Alliance of Massachusetts
Health Decisions Contributes Adaptive Research Best Practices to Wiley’s "Clinical Trials Handbook"
CEO Michael Rosenberg authors an in-depth review of progressive research in new interdisciplinary manual - August 15, 2009 - Health Decisions
Macular Degeneration: Exclusive Interview with Researcher Dr. Janet Sunness M.D. of the Greater Baltimore Medical Center
Exclusive interview with researcher Dr. Janet Sunness of the Greater Baltimore Medical Center concerning an advanced form of Macular Degeneration known as Geographic Atrophy. - August 13, 2009 - Macular Degeneration Foundation
ALPCO Appoints Stratech Scientific as Their New Distribution Channel in the UK
Stratech Scientific is a distributor of high quality products for research laboratories throughout the UK and Europe. ALPCO Diagnostics is a leading developer and distributor of high quality immunoassay kits in the US. The two companies feel that their mutual commitment to offering quality products in the life science research area will be the basis for a strong partnership. - August 13, 2009 - ALPCO
Drug-Device Combination Market Worth US $18.54 Billion by 2014
Market of Drug-device combination is expected to be worth US $18.54 billion by 2014 - August 07, 2009 - marketsandmarkets
XTractor Premium Surpasses 200,000 Mark of Expert Annotated PubMed Facts
Molecular Connections announced today, that their XTractor Premium platform surpasses 200,000 "Expert" annotated facts from PubMed. - August 07, 2009 - Molecular Connections Pvt. Ltd.
Advances in Ovarian Tumor Therapy Made at the Lankenau Institute for Medical Research - Cancer Research Paper Shows Nanoparticle Delivery System Slowed Ovarian Tumor Grow
Dr. Janet Sawicki, Professor at the Lankenau Institute for Medical Research (LIMR), along with its collaborating institution, the Massachusetts Institute of Technology (MIT), published a paper in Cancer Research whose findings suggest a potential new therapy to treat advanced stage ovarian cancer. - August 01, 2009 - Lankenau Institute for Medical Research
International Cellular Medicine Society Seeks to Educate Patients on Off-Shore Stem Cells Clinics
Stem cell clinics in nearly 20 countries have been actively advertising new stem cell therapies for a myriad of diseases ranging from congestive heart failure to ALS. To help patients, the ICMS has launched a comprehensive study of promises and downsides of off shore stem cell therapies and clinics. - July 19, 2009 - International Cellular Medicine Society
Dr. Patrick Bitter, Sr. M.D. Joins Vascular Health Specialists
After several months of in-depth collaboration, Dr. Patrick Bitter Sr., a dermatologist and rosacea treatment expert, has joined Vascular Health Specialists LLC. - June 26, 2009 - Vascular Health Specialists LLC
North American Seminars, Inc. Is Looking for Medical Professionals and Medical Content Writers and Researchers
North American Seminars, Inc. is expanding and looking for medical professionals to assist in the creation of educational material and present live education training across the United States and Europe. - June 16, 2009 - North American Seminars
168 Electronic Cigarette Users Give Their Opinions in E Cigarette Direct Survey
In an E Cigarette Direct survey Electronic Cigarette Users voice their opinion on the electronic cigarette, their health, quitting and the upcoming US ban on the device. - June 14, 2009 - Gower Entreprises
Lankenau Institute for Medical Research Investigator Receives March of Dimes Grant: Research Focused on Congenital Defects of the Eye in Newborns Using a Stem Cell Model
Dr. Mindy George-Weinstein, Professor at the Lankenau Institute for Medical Research (LIMR), in collaboration with Dr. Sue Menko, Professor at Thomas Jefferson University, received a three-year grant in the amount of $264,410 from the March of Dimes to study the development of eye defects that may lead to cataracts, glaucoma, increased sensitivity to light, squinting or blindness in newborns. - June 13, 2009 - Lankenau Institute for Medical Research
Mighty Microbes Launches Updated Website
Mighty Microbes, featuring probiotics to boost your immune system, enhance your energy and promote overall better health, has announced the launch of their updated website http://www.MightyMicrobes.com. - June 13, 2009 - Mighty Microbes
Hereditary Neuropathy Foundation Announces Major Research Effort
The Hereditary Neuropathy Foundation announced today that it will be funding a major research effort to find a cure for Charcot-Marie-Tooth disease. - June 12, 2009 - Hereditary Neuropathy Foundation
Integrated Clinical Trial Services Releases White Paper On Medical Science Liaisons (MSL)
Tom Sturgis, president of ICTS (Integrated Clinical Trial Services), a full-service patient enrollment firm that utilizes more than 300 contract employees internationally to provide clinical trial patient recruitment, enrollment, retention and pharmaceutical development, has announced the release... - June 10, 2009 - Integrated Clinical Trial Services
S.L.E. Lupus Foundation, 1st Lupus Organization Ever Selected as Charity Partner for ING New York City Marathon
The S.L.E. Lupus Foundation has been selected as an official charity for the ING New York City Marathon 2009, making it the first lupus organization ever to host a team in this famous race that has a broadcast reach to more than 300 million people worldwide. The Foundation currently has 25 openings for runners to participate in their “Team Life Without Lupus.” - June 09, 2009 - S.L.E. Lupus Foundation
ENCO Pharmaceutical Development Announces Addition of Keith Hurley as Vice-President of Sales and Marketing
ENCO Pharmaceutical Development, Inc. is pleased to announce the addition of Mr. Keith Hurley to its staff as Vice-President of Sales and Marketing. - June 06, 2009 - Enco Pharmaceutical Development, Inc.
42 market research Shortlisted for TECOM Investments Pearl Award
42 market research, a leading market research provider for the healthcare industry, has been shortlisted by TECOM Investments for the Pearl Award for Globalisation and Diversification. “The achievement of 42 market research is highly commendable and to be shortlisted in the category of... - June 05, 2009 - 42 market research
Infonetica Announce Launch of Online GCP Training for USA
Infonetica is happy to announce the launch of a US online GCP training satisfying ICH and FDA criteria, which are essential to Good Clinical Practice regulations. - May 24, 2009 - Infonetica Ltd